(Q51785189)

English

Temporal expression of the PGE2 synthetic system in the kidney is associated with the time frame of renal developmental vulnerability to cyclooxygenase-2 inhibition.

scientific article published on 9 May 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/22573380

Temporal expression of the PGE2 synthetic system in the kidney is associated with the time frame of renal developmental vulnerability to cyclooxygenase-2 inhibition. (English)

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/22573380

author name string

Stefanie Frölich

1

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/22573380

Anke Olliges

2

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/22573380

Niklas Kern

3

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/22573380

Yannik Schreiber

4

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/22573380

Shuh Narumiya

5

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/22573380

Rolf M Nüsing

6

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/22573380

publication date

9 May 2012

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/22573380

American Journal of Physiology - Renal Physiology

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/22573380

303

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/22573380

2

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/22573380

F209-19

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/22573380

Nephron mass and cardiovascular and renal disease risks

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00418.2011

21 January 2018

Role of the kidney in the prenatal and early postnatal programming of hypertension

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00418.2011

21 January 2018

Differential effects of maternal nutrient restriction through pregnancy on kidney development and later blood pressure control in the resulting offspring

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00418.2011

21 January 2018

Consequences of altered eicosanoid patterns for nociceptive processing in mPGES-1-deficient mice

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00418.2011

21 January 2018

Key enzymes for renal prostaglandin synthesis: site-specific expression in rodent kidney (rat, mouse)

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00418.2011

21 January 2018

Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II.

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00418.2011

21 January 2018

Role of microsomal prostaglandin E synthase 1 in the kidney.

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00418.2011

21 January 2018

Prostaglandin E2 EP2 and EP4 receptor activation mediates cAMP-dependent hyperpolarization and exocytosis of renin in juxtaglomerular cells

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00418.2011

21 January 2018

Physiological regulation of prostaglandins in the kidney

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00418.2011

21 January 2018

Prostaglandin E synthases: Understanding their pathophysiological roles through mouse genetic models

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00418.2011

21 January 2018

Cessation of renal morphogenesis in mice

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00418.2011

21 January 2018

Abortive expansion of the cumulus and impaired fertility in mice lacking the prostaglandin E receptor subtype EP(2)

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00418.2011

21 January 2018

The renin-angiotensin system in kidney development: role of COX-2 and adrenal steroids

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00418.2011

21 January 2018

mPGES-1 deletion impairs aldosterone escape and enhances sodium appetite

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00418.2011

21 January 2018

Deletion of microsomal prostaglandin E synthase-1 increases sensitivity to salt loading and angiotensin II infusion

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00418.2011

21 January 2018

Reduced pain hypersensitivity and inflammation in mice lacking microsomal prostaglandin e synthase-1.

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00418.2011

21 January 2018

Cyclooxygenase-2 expression in the developing human kidney

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00418.2011

21 January 2018

Localization of cyclooxygenase-1 and -2 in adult and fetal human kidney: implication for renal function.

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00418.2011

21 January 2018

Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration.

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00418.2011

21 January 2018

cPGES/p23 is required for glucocorticoid receptor function and embryonic growth but not prostaglandin E2 synthesis

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00418.2011

21 January 2018

Low endogenous glucocorticoid allows induction of kidney cortical cyclooxygenase-2 during postnatal rat development

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00418.2011

21 January 2018

Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse.

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00418.2011

21 January 2018

Cellular prostaglandin E2 production by membrane-bound prostaglandin E synthase-2 via both cyclooxygenases-1 and -2.

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00418.2011

21 January 2018

Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00418.2011

21 January 2018

Postnatal development and progression of renal dysplasia in cyclooxygenase-2 null mice

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00418.2011

21 January 2018

Defects in mouse nephrogenesis induced by selective and non-selective cyclooxygenase-2 inhibitors

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00418.2011

21 January 2018

Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib).

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00418.2011

21 January 2018

Stimulation of renin release by prostaglandin E2 is mediated by EP2 and EP4 receptors in mouse kidneys

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00418.2011

21 January 2018

Prostanoids in health and disease

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00418.2011

21 January 2018

Cyclooxygenase-2 contributes to elevated renin in the early postnatal period in rats

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00418.2011

21 January 2018

Molecular identification of cytosolic prostaglandin E2 synthase that is functionally coupled with cyclooxygenase-1 in immediate prostaglandin E2 biosynthesis

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00418.2011

21 January 2018

Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00418.2011

21 January 2018

Lipopolysaccharide-dependent prostaglandin E(2) production is regulated by the glutathione-dependent prostaglandin E(2) synthase gene induced by the Toll-like receptor 4/MyD88/NF-IL6 pathway

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00418.2011

21 January 2018

Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00418.2011

21 January 2018

Persistent anuria, neonatal death, and renal microcystic lesions after prenatal exposure to indomethacin.

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00418.2011

21 January 2018

Immunohistochemical Expressions of Main PGE(2) Biosynthesis-related Enzymes and PGE(2) Receptor in Rat Nephrogenesis

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00418.2011

21 January 2018

Stimulation of bone formation and prevention of bone loss by prostaglandin E EP4 receptor activation

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00418.2011

21 January 2018

Identifiers

10.1152/AJPRENAL.00418.2011

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/22573380

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/22573380

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51785189&oldid=1234923098"